腹腔镜与开腹远端胃切除术联合D2淋巴结清扫治疗临床T4a期胃癌:UMC-UPPERGI-01随机临床试验
UMC-UPPERGI-01单中心非劣效性随机试验纳入208例临床T4a期胃癌患者,比较腹腔镜与开腹远端胃切除联合D2淋巴结清扫的短期结局。两组30天并发症和死亡率无显著差异,腹腔镜组手术时间更长、出血量更多,但术后恢复指标无差异。结果表明在有经验术者手中腹腔镜可作为开腹手术的替代选择。
要点
- 腹腔镜与开腹远端胃切除联合D2清扫治疗临床T4a期胃癌的30天并发症和死亡率无显著差异
- 腹腔镜组手术时间显著更长且出血量更多,但术后恢复指标无差异
- 合并症是术后并发症的独立危险因素(OR 2.42,95%CI 1.11-5.30)
核心结论
- 在UMC-UPPERGI-01非劣效性随机试验中,腹腔镜远端胃切除治疗临床T4a期胃癌的短期结局与开腹手术相当。
- 结果提示有经验的术者可将腹腔镜作为开腹远端胃切除的替代选择。
- 长期肿瘤学结局有待持续随访确定。
研究设计与样本
- UMC-UPPERGI-01为单中心、开放标签、非劣效性随机临床试验,在越南胡志明市一家三级医院开展。
- 研究纳入临床T4a期胃癌患者,2020年6月至2025年4月进行,2023年10月和2025年6月分别进行中期和短期结果分析。
- 全分析集共208例接受根治性远端胃切除联合D2淋巴结清扫的患者,腹腔镜组和开腹组各104例,两组无交叉。
主要发现
- 两组在首次排气时间、口服耐受时间、术后住院时间和术后至开始辅助化疗时间方面无显著差异。
临床怎么用
- 对于临床T4a期胃癌,有经验的术者可选择腹腔镜远端胃切除联合D2淋巴结清扫作为开腹手术的替代方案。
- 术前应评估合并症,合并症是术后并发症的独立危险因素。
局限性
- 本研究为单中心研究,结果外推需谨慎。
- 当前报告为短期结果,长期肿瘤学结局尚未确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: No prospective trial on laparoscopy has been specifically designed for clinical T4a gastric cancer (GC); evidence of the safety and efficacy of laparoscopy for T4a GC is currently insufficient. OBJECTIVE: To compare the short-term surgical outcomes between laparoscopic distal gastrectomy (LDG) and open distal gastrectomy (ODG) with D2 lymph node dissection for patients with clinical T4a GC. DESIGN, SETTING, AND PARTICIPANTS: The UMC-UPPERGI-01 randomized clinical trial (RCT) was a single-center, open-label, noninferiority RCT conducted at a tertiary hospital in Ho Chi Minh City, Vietnam, among patients with clinical T4a GC. The study was conducted from June 2020 to April 2025. Interim and short-term results analyses were conducted in October 2023 and June 2025, respectively. INTERVENTIONS: Patients were randomly assigned 1:1 to undergo LDG or ODG with D2 lymph node dissection as the full analysis set of the UMC-UPPERGI-01 trial. The procedures were performed exclusively by qualified surgeons. MAIN OUTCOMES AND MEASURES: Short-term outcomes included surgical results, pathological characteristics, 30-day postoperative morbidity and mortality (Clavien-Dindo classification), and postoperative recovery parameters. RESULTS: A total of 208 patients who underwent curative-intent distal gastrectomy with D2 lymphadenectomy were included in the full analysis set, with 104 patients in each group. There was no crossover between the 2 groups. Patients in the LDG group had a mean (SD) age of 61.1 (10.0) years and included 25 female patients (24.0%). Patients in the ODG group had a mean (SD) age of 60.0 (10.7) years and included 29 female patients (27.9%). No significant differences were found between the LDG and ODG groups in 30-day morbidity and mortality, including rates of any postoperative complication (22.1% vs 21.2%; P = .87) and severe complications (2.9% vs 3.8%; P > .99). The LDG group showed nonsignificant differences regarding surgical complications (21.2% vs 16.4%; P = .37) and general complications (3.9% vs 10.6%; P = .11) compared to the ODG group. The LDG group had significantly longer mean (SD) operative time (220.0 [42.4] minutes vs 153.7 [36.7] minutes; P < .001) and higher median (IQR) blood loss (80 [50-145] mL vs 50 [30-100] mL; P = .003). There were no significant differences in terms of time to the first flatus, time to oral tolerance, length of postoperative hospital stay, and time from surgery to initiation of adjuvant chemotherapy. Comorbidity was identified as an independent risk factor for postoperative complications in multivariate analysis (odds ratio, 2.42; 95% CI, 1.11-5.30; P = .03). CONCLUSIONS AND RELEVANCE: In the UMC-UPPERGI-01 noninferiority RCT, LDG showed comparable short-term outcomes to ODG for T4a GC. The results suggest that LDG can be recommended as an alternative to ODG by qualified surgeons for clinical T4a GC; ongoing follow-up will determine long-term oncologic outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04384757.
引用
- Dat TQ, Thong DQ, Nguyen DT, et al. Laparoscopic vs Open Distal Gastrectomy With D2 Lymphadenectomy for Clinical T4a Gastric Cancer: The UMC-UPPERGI-01 Randomized Clinical Trial. JAMA Surg. 2026. PMID: 41222957. doi:10.1001/jamasurg.2025.4929
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。